Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Neuland Laboratories

    Client Virtual Booth

    NEULAND LABORATORIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    • Difelikefalin

    • Empagliflozin

    • Fezolinetant

    • Mirabegron

    • Paliperidone

    • Paliperidone Palmitate

    • Tapinarof

    • Tirzepatide

    • Vilanterol Trifenatate

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neuland VB RM
    Neuland Laboratories
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    11th Floor (5th Level), Phoenix IVY Building, Plot No. 573A-III, Road No. 82, Jubilee Hills, Hyderabad, 500033, Telangana
    Telephone
    Telephone
    +91 4067611600
    Client Email
    Email
    marketing@neulandlabs.com
    Client Website
    Website
    https://www.neulandlabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuland-laboratories-limited/
    Twitter
    Twitter
    https://twitter.com/neulandlabs
    Contact Info
    Others

    Full View ScreenFull Screen View
    Goldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab
    Goldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab

    https://www.moneycontrol.com/news/business/earnings/goldman-sach-initiates-buy-on-syngene-neuland-adds-sell-tag-to-larus-lab-12625281.html

    MONEYCONTROL
    11 Apr 2024
    Share Share
    Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility
    Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility

    https://www.moneycontrol.com/news/business/markets/neuland-labs-zooms-5-on-us-fda-all-clear-for-hyderabad-facility-12509081.html

    MONEYCONTROL
    25 Mar 2024
    Share Share
    Neuland Lab Consolidated June 2023 Net Sales at Rs 362.99 crore, up 64.12% Y-o-Y
    Neuland Lab Consolidated June 2023 Net Sales at Rs 362.99 crore, up 64.12% Y-o-Y

    https://www.moneycontrol.com/news/business/earnings/neuland-lab-consolidated-june-2023-net-sales-at-rs-362-99-crore-up-64-12-y-o-y-11092611.html

    MONEY CONTROL
    03 Aug 2023
    Share Share
    Neuland Labs Share Jumps 44% in 3 Days on Strong Q4 Results
    Neuland Labs Share Jumps 44% in 3 Days on Strong Q4 Results

    https://www.equitypandit.com/neuland-labs-share-jumps-44-in-3-days-on-strong-q4-results/

    EQUITYPANDIT
    15 May 2023
    Share Share
    Neuland Laboratories appoints Abhijit Majumdar as CFO
    Neuland Laboratories appoints Abhijit Majumdar as CFO

    https://www.indianpharmapost.com/people/neuland-laboratories-appoints-abhijit-majumdar-as-cfo-13331

    INDIANPHARMAPOST
    24 Nov 2022
    Share Share
    SE Intimation – Appointment of CFO & Approval for transfer of Company's property situated at Nanakramguda, Hyderabad by way of perpetual lease
    SE Intimation – Appointment of CFO & Approval for transfer of Company's property situated at Nanakramguda, Hyderabad by way of perpetual lease

    https://www.neulandlabs.com/wp-content/uploads/2022/11/SE-Intimation_November-23-2022_signed.pdf

    PRESS RELEASE
    23 Nov 2022
    Share Share
    End-to-End Focus on Quality in API Manufacturing
    End-to-End Focus on Quality in API Manufacturing

    https://www.neulandlabs.com/blog/2022/10/31/end-to-end-focus-on-quality-in-api-manufacturing/

    Saharsh Davuluri PRESS RELEASE
    31 Oct 2022
    Share Share
    Ensuring Rock-Solid IT Infrastructure in Contract Manufacturing
    Ensuring Rock-Solid IT Infrastructure in Contract Manufacturing

    https://www.neulandlabs.com/blog/2022/09/30/ensuring-rock-solid-it-infrastructure-in-contract-manufacturing/

    Saharsh Davuluri PRESS RELEASE
    30 Sep 2022
    Share Share
    Neuland Annual Report FY 2021-22
    Neuland Annual Report FY 2021-22

    https://www.neulandlabs.com/wp-content/uploads/2022/09/Neuland_Annual-Report-FY2022.pdf

    PRESS RELEASE
    27 Sep 2022
    Share Share
    SE Intimation – Resignation of Chief Financial Officer
    SE Intimation – Resignation of Chief Financial Officer

    https://www.neulandlabs.com/wp-content/uploads/2022/09/SE-Intimation-CFO-Resignation.pdf

    PRESS RELEASE
    13 Sep 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Neuland VB RM

    CPhI Japan

    Booth #5K-08

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search